This finding may reflect a synergistic effect in this subgroup, combining obesity-related enhancements in immune responsiveness, as previously described, with the well-established association between high PD-L1 expression and improved efficacy of ICIs [29]. This evidence concerns the gene CD274 and obesity disorder.